These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 37965307

  • 1. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C, Chai W, Han J, Zhang Z, Liu X, Yang S, Wang Y, Wang D, Wan F, Fan Z, Hu H.
    Front Immunol; 2023; 14():1213947. PubMed ID: 37965307
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor immune microenvironment-based clusters in predicting prognosis and guiding immunotherapy in breast cancer.
    Liu Y, He X, Yang YI.
    J Biosci; 2024; 49():. PubMed ID: 38287674
    [Abstract] [Full Text] [Related]

  • 7. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW, Guan JZ, Long YP, Song Q, Xiong Q, Qin BY, Ma ZQ, Hu Y, Yang B.
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
    Cui H, Ren X, Dai L, Chang L, Liu D, Zhai Z, Kang H, Ma X.
    Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
    [Abstract] [Full Text] [Related]

  • 9. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C, Tang Y, Ma H, Wei S, Hu X, Zhao L, Wang G.
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer.
    Cao M, Cao Y, Xue S, Zhang Q, Zhang H, Xue W.
    Altern Ther Health Med; 2024 Apr; 30(4):130-138. PubMed ID: 38518167
    [Abstract] [Full Text] [Related]

  • 11. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z, Liu H, Gong Y, Cheng Y.
    Eur J Med Res; 2022 Dec 29; 27(1):317. PubMed ID: 36581948
    [Abstract] [Full Text] [Related]

  • 12. A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer.
    Liu Z, Qi T, Li X, Yao Y, Othmane B, Chen J, Zu X, Ou Z, Hu J.
    Front Immunol; 2021 Dec 29; 12():791924. PubMed ID: 34975891
    [Abstract] [Full Text] [Related]

  • 13. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B, Tong F, Zhai C, Wang L, Liu Y, Wang J.
    Dis Markers; 2021 Dec 29; 2021():3385058. PubMed ID: 34721733
    [Abstract] [Full Text] [Related]

  • 14. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z, Tu L, Chen M, Tong S.
    BMC Cancer; 2021 Jun 10; 21(1):692. PubMed ID: 34112144
    [Abstract] [Full Text] [Related]

  • 15. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes.
    Yang M, Su Y, Xu K, Zheng H, Cai Y, Wen P, Yang Z, Liu L, Xu P.
    J Immunol Res; 2024 Jun 10; 2024():6595252. PubMed ID: 39431237
    [Abstract] [Full Text] [Related]

  • 16. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J, Cao J, Li P, Yao Z, Deng R, Ying L, Tian J.
    BMC Cancer; 2021 Jul 27; 21(1):858. PubMed ID: 34315402
    [Abstract] [Full Text] [Related]

  • 17. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J, Xu L, Fu W, Sun Y, Wang N, Zhang J, Yang C, Zhang X, Zhou Y, Wang R, Zhang H, Mou R, Du X, Li X, Hu S, Xie R.
    Funct Integr Genomics; 2023 Aug 31; 23(3):286. PubMed ID: 37650991
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive analysis of LD-related genes signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Jia Y, Dong X, Yang F, Zhou L, Long H.
    BMC Nephrol; 2024 Sep 10; 25(1):298. PubMed ID: 39256647
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.